Since 2008, when CEO Robert Moussa joined the company, Dilon Diagnostics has set in motion several initiatives to increase its organizational quality. Among them have been receiving the European Medical Device “CE Mark” for its breast imaging devices and the EN ISO 13485 Quality Management Systems for Medical Devices certification.

These important milestones and others have been recognized with Dilon Diagnostics’ inclusion on Quality magazine’s 2010 Quality Leadership 100 list.

More than 800 manufacturers were rated on criteria such as scrap and rework as a percentage of sales, warranty costs as a percentage of sales, and contribution of quality to profitability and shareholder value. Companies were also evaluated on quality programs that were used to improve their performance.


(Source: Press Release)